Front Row Advisors’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.1K Buy
2,350
+750
+47% +$18.9K 0.02% 218
2026
Q1
$40.5K Hold
1,600
0.01% 242
2025
Q4
$40.7K Hold
1,600
0.01% 235
2025
Q3
$40.8K Hold
1,600
0.01% 232
2025
Q2
$40.7K Hold
1,600
0.01% 229
2025
Q1
$40.4K Hold
1,600
0.02% 233
2024
Q4
$39.8K Hold
1,600
0.01% 239
2024
Q3
$40.8K Hold
1,600
0.01% 236
2024
Q2
$39.6K Hold
1,600
0.01% 297
2024
Q1
$39.8K Hold
1,600
0.01% 287
2023
Q4
$40.1K Hold
1,600
0.02% 195
2023
Q3
$38.4K Hold
1,600
0.02% 262
2023
Q2
$39K Hold
1,600
0.02% 269
2023
Q1
$40K Buy
+1,600
New +$39.5K 0.02% 265

Other funds holding IBDT

Front Row Advisors's IBDT Position: Q2 2026 in Review

Front Row Advisors increased its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 47% in Q2 2026, buying an estimated $18.9K and bringing the position to 2,350 shares worth $59.1K. The position accounts for 0.02% of the portfolio, ranked #218.

Front Row Advisors first reported a position in IBDT in Q1 2023 and has held it in 14 quarters since. 435 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.

  • Front Row Advisors held 2,350 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $59.1K as of Q2 2026.
  • Front Row Advisors bought 750 iShares iBonds Dec 2028 Term Corporate ETF shares in Q2 2026, an estimated $18.9K.
  • iShares iBonds Dec 2028 Term Corporate ETF made up 0.02% of Front Row Advisors's portfolio in Q2 2026, its #218 holding.
  • Front Row Advisors first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q1 2023 and has held it in 14 quarters since.
  • 435 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.

Based on Front Row Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.